The Vanguard Group Discloses Stake in Spire Healthcare

The Vanguard Group, Inc. has announced its equity position in Spire Healthcare Group plc as part of its obligation under Rule 8.3 of the Takeover Code. The disclosure, dated March 31, 2026, indicates that Vanguard holds a 3.59% interest in Spire's 1p ordinary shares, amounting to 14,467,396 shares.

The form reveals a recent transaction involving the sale of 2,232 ordinary shares at a price of 1.45 GBP each. No positions in cash-settled or stock-settled derivatives were reported, nor any indemnity arrangements related to Spire's securities. Additionally, no agreements for options or derivatives have been established.

This disclosure underscores Vanguard's status as a significant stakeholder in Spire Healthcare, aligning with standard practices for managing large equity interests.